Infections due to antimicrobial-resistant pathogens in the dialysis unit

Blood Purification

Volumn 18, Issue 4, 2000, Pages 355-360

  Tokars, Jerome I ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN DERIVATIVE; IMIPENEM; INFLUENZA VACCINE; METICILLIN; PNEUMOCOCCUS VACCINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; CONFERENCE PAPER; HEALTH SURVEY; HEMODIALYSIS; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; QUALITY CONTROL; RISK FACTOR;

EID: 0033808228     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000014462     Document Type: Conference Paper

References (31)

1. Smith T, Pearson ML, Wilcox K, Cruz C, Lancaster MW, Robinson-Dunn B, et al: Emergence of vancomycin resistance in Staphylococcus aureus. N Engl J Med 1999;340:493-501.
2. Centers for Disease Control and Prevention: Staphylococcus aureus with reduced susceptibility to vancomycin - Illinois, 1999. MMWR 2000;48:1165-1167.
3. National Nosocomial Infections Surveillance System: Semiannual report, December 1999. Atlanta, GA, U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, 1999.
4. Fridkin SK, Gaynes RP: Antimicrobial resistance in intensive care units. Clinics in Chest Medicine 1999;20:303-316.
5. Uttley AHC, George RC, Naidoo J, Woodford N, Johnson AP, Collins CH, et al: High-level vancomycin-resistant enterococci causing hospital infections. Epidemiol Infect 1989;103: 173-181.
6. Stroud L, Edwards J, Danzig L, Culver D, Gaynes R: Risk factors for mortality associated with enterococcal blood stream infections. Infect Control Hosp Epidemiol 1996;17:576-580.
7. Shay DK, Maloney SA, Montecalvo M, Banerjee S, Wormser GP, Arduino MJ, et al: Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections. J Infect Dis 1995;172:993-1000.
8. Singer DA, Jochimsen EM, Gielerak P, Jarvis WR: Pseudo-outbreak of Enterococcus durans infections and colonization associated with introduction of an automated identification system software update. J Clin Microbiol 1996;34: 2685-2687.
9. Tokars JI, Miller ER, Alter MJ, Arduino MJ: National surveillance of dialysis-associated diseases in the United States, 1997. Atlanta, GA, Public Health Service, Department of Health and Human Services, 1998.
10. Fishbane S, Cunha BA, Mittal SK, Ruggian J, Shea K, Schock PE: Vancomycin-resistant enterococci in hemodialysis patients is related to intravenous vancomycin use [letter]. Infect Control Hosp Epidemiol 1999;20:461-462.
11. Roghmann MC, Fink JC, Polish L, Maker T, Brewrink J, Morris JG Jr, et al: Colonization with vancomycin-resistant enterococci in chronic hemodialysis patients. Am J Kidney Dis 1998;32:254-257.
12. Brady JP, Snyder JW, Hasbargen JA: Vancomycin-resistant enterococcus in end-stage renal disease. Am J Kidney Dis 1998;32:415-418.
13. Garrison T, Traynor P, Windus D, Lu S, Bulliner C, Mundy L: Independent risks tor vancomycin-resistant Enterococcus faecium in hemodialysis patients. SHEA 1998 Annual Meeting Abstracts 1998;19:683 [Abstract].
14. Descheemaeker P, Ieven M, Chapelle S, Lammens M, Hauchecorne M, Wijdooghe M. et al: Prevalence and molecular epidemiology of glycopeptide-resistant enterococci in Belgian renal dialysis units. J Infect Dis 2000;181:235-241.
15. Tokars J, Gehr T, Parrish J, Qaiyumi S, Miller E. Armistead N, Light P: Vancomycin resistant enterococci colonization at selected outpatient hemodialysis centers [Abstract A3012]. American Society for Nephrology 33rd Annual Meeting, Miami FL, 1999.
16. Centers for Disease Control and Prevention: Laboratory capacity to detect antimicrobial resistance, 1998. MMWR 2000;48:1167-1171.
17. Weinstein MP, Towns ML, Quartey SM, Mirrett S, Reimer LG, Parmigiani G, et al: The clinical significance of positive blood cultures in the 1990s: A prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 1998;24:584-602.
18. Centers for Disease Control and Prevention: Recommendations for preventing the spread of vancomycin resistance. MMWR 1995;44(No. RR-12):1-13.
19. Raad I, Alrahwan A, Rolston K: Staphylococcus epidermidis: Emerging resistance and need for alternative agents. Clin Infect Dis 1998;26: 1182-1187.
20. Sieradzki K, Roberts RB, Serur D, Hargrave J, Tomasz A: Heterogeneously vancomycin-resistant Staphylococcus epidermidis strain causing recurrent peritonitis in a dialysis patient during vancomycin therapy. J Clin Microbiol 1999; 37:39-44.
21. Fogel MA, Nussbaum PB, Feintzeig ID, Hunt WA, Gavin JP, Kim RC: Use of cefazolin in chronic hemodialysis patients: A safe and effective alternative to vancomycin. Am J Kidney Dis 1998;32:401-409.
22. Marx MA, Frye RF, Matzke GR, Golper TA: Cefazolin as empiric therapy in hemodialysis-related infections: Efficacy and blood concentrations. Am J Kidney Dis 1998;32:410-414.
23. Churchill DN, Taylor DW, Cook RJ, LePlante P, Barre P, Cartier P, et al: Canadian hemodialysis morbidity study. Am J Kidney Dis 1992; 19:214-234.
24. Padberg FT Jr, Lee BC, Curl GR: Hemoaccess site infection. Surgery Gynecol Obstet 1992; 174:103-108.
25. Kaplowitz LG, Comstock JA, Landwehr DM, Dalton HP, Mayhall CG: A prospective study of infections in hemodialysis patients: Patient hygiene and other risk factors for infection. Infect Control Hosp Epidemiol 1988;9:534-541.
26. Bonomo RA, Rice D, Whalen C, Linn D, Eckstein L, Shlaes DM: Risk factors associated with permanent access-site infections in chronic hemodialysis patients. Infect Control Hosp Epidemiol 1997;18:757-761.
27. Tokars JI, Light P, Armistead N, Parrish J, Miller ER, Gehr T: Risk factors for vascular access infections among hemodialysis outpatients [abstract 3013]. American Society for Nephrology 33rd Annual Meeting, Miami, FL, 1999.
28. Favero MA, Tokars JI, Arduino MJ, Alter MJ: Nosocomial infections associated with hemodialysis; in Mayhall CG (ed): Hospital epidemiology and infection control. Philadelphia, Lippincott Williams & Wilkins 1999;897-918.
29. Pearson ML: The Hospital Infection Control Practices Advisory Committee: Guideline for prevention of intravascular device-related infections. Am J Infect Control 1996;24:262-293.
30. National Kidney Foundation: Dialysis outcomes quality initiative: Clinical practice guidelines. Am J Kidney Dis 1997;30:S137-S240.
31. Gaynes RP, Culver DH, Emori TG, Horan TC, Banerjce SN, Edwards JE, et al: The National Nosocomial Infections Surveillance system: Plans for the 1990's and beyond. Am J Med 1991;91(suppl 3B):116S-120S.